Tuesday, May 30, 2023


Biotechnology News Magazine


Calliditas Receives Conditional Marketing Authorization from UK MHRA for Kinpeygo in IgA Nephropathy

Kinpeygo is the first and only approved treatment for IgAN, a rare, progressive autoimmune disease of the kidney with a high unmet need, with more than 50% of patients potentially progressing to end-stage renal disease.

Neuraxpharm Completes its Presence in Benelux by Opening an Affiliate in Brussels to Cover Belgium and Luxembourg

Dr. Pierre-Hervé Brun will be Country Manager for Neuraxpharm Belgium, alongside his current role as Country Manager for Neuraxpharm France.

Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer’s Disease in Japan

In the Clarity AD study, lecanemab treatment resulted in highly statistically significant results, reducing clinical decline on the global cognitive and functional scale as the primary endpoint (CDR-SB(2).

Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia

Venetoclax is a BCL-2 inhibitor approved by the U.S. Food and Drug Administration (FDA) for treatment of several hematologic cancers, including in combination with azacytidine for elderly patients with AML unable to tolerate the standard of care.

QleanAir Partnership to Support Work of Two Faculty Members Aiming to Reduce Occurrences of Contamination in Compounding Pharmacies with AI

A partnership with QleanAir, along with previous grant support from the Eshelman Institute for Innovation (EII), will drive their work forward.

Schreiner MediPharm & SCHOTT Pharma Debut Prefilled Syringes with RFID-Labels

Previously, the ongoing partnership between Schreiner MediPharm and SCHOTT Pharma had been focused primarily on equipping COC syringes with analog functional labels. With this latest effort, the two pharmaceutical packaging experts are digitizing prefilled syringes.